Dr Braden Te Ao

Ph.D, MPH (Hons), BHSc


I am a Lecturer and Health Economist based in the Health Systems section of the School of Population Health whose interest includes access, quality, and efficiency of health care services. In particular, I have strong interests in evaluating the cost-effectiveness of interventions aimed at reducing health disparities for socially disadvantaged populations. I have conducted and published research in economic evaluations including a cost of illness study for traumatic brain injury, cost-effectiveness evaluation of new drugs and technologies (e.g., genetic testing for patients with acute coronary syndrome, tiotropium treatment for bronchiectasis patients), and cost-effectiveness of existing health services (e.g., hospital-based services for stroke). Previously I've held an academic position with Auckland University of Technology with a part time secondment to the Middlemore Clinical Trials Team at Middlemore Hospital.

Research | Current

HRC Programme Grant

  1. Measuring and reducing stroke burden in New Zealand (HRC 20/680 Feigin)

HRC Project Grant

  1. BIONIC2: TBI incidence, causes, costs over time and service access in NZ (HRC 20/193 Jones)
  2. Reducing fatigue after stroke: A randomised controlled trial (HRC18/147 Jones)
  3. Evaluating a sustainable model of peer mentoring in traumatic brain injury (HRC18/311 Kayes)

HRC Feasibility Grant

  1. Prophylactic InCisional antibiotics in skin surgery (PICASSo) Trial (HRC 18/656 Mathy)

HRC Emerging Researcher First Grant

  1. Are concussion services for mild traumatic brain injury cost effective? (HRC 19/591 Te Ao)

I am currently involved in National Institute for Stroke & Applied Neurosciences research projects (BIONIC, ARCOS IV, MD-PREV), National Institute for Public Health and Mental Health Research 'Gambling Intervention' trial and Interdisciplinary Trauma Research Centre 'Healthy Relationships' study at Auckland University of Technology. Prevalence of Status Epilepticus study in Auckland led by Auckland District Health Board and a Cost of Māori health inequalities study funded by Ngā Pae o te Māramatanga.


Health Economics

Health care Financing, Budget Impact analysis

Cost-Effectiveness & Cost-Utility Analysis

Economic evaluations of health initiatives, health technology assessment, and prioritisation of healthcare initiatives.

Public Health System & Health Services Research

Inequalities (access to care) and disparities (health status, health outcomes and experiences) in health/ Unmet needs for stroke and traumatic brain injury survivors and/or  other socially disadvantaged groups

Teaching | Current

Course Director POPLHLTH 215: Dynamics of Health Systems (BHSc)

Course Director POPLHLTH 719: Health Economics (MPH, MHSc, MHL)

Postgraduate supervision

Completed Master of Public Health Thesis

Student Name

Year completed

Title of Thesis

Primary /Secondary Supervisor

Harpreet Singh


Quality of Life Valuations for Traumatic Brain Injury States



Completed Master of Philosophy Thesis

Student Name

Year completed

Title of Thesis

Primary /Secondary Supervisor

Christin Coomarasamy


Cost-effectiveness analysis of Tiotropium treatment for Bronchiectasis: Evidence from a crossover randomized trial


Hannaneh Safardokht


Designing a forecasting model for inpatient occupancy in Middlemore Hospital, Auckland



2019 Recipient of the Health Research Council of New Zealand Emerging Researcher First Grant Award


2017 Recipient of the Visiting Health Economic Scholar Program, Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne.


2011-2013 Health Research Council of New Zealand Ph.D. fellowship


Health Systems Pathway Champion for the BHSc programme

Areas of expertise

Health Services Research and Cost-Effectiveness Evaluation (trial-based and non trial based)


Committees/Professional groups/Services


  • Member of the Procare Māori Advisory Committee


  • Steering Committee Member of the HRC's Enhancing New Zealand's Clinical Trials RFP


  • Global Burden of Disease, Injuries and Healthcare Financing Collaborator
  • Committee Member of the Medical Research Future Fund (MRFF) Grant Assessment Committee (GAC) for Medical Research Future Fund – Traumatic Brain Injury Mission, 2020 funding round. (2020-present)
  • New Zealand Emerging Researcher Representative, Health Services Research Association of Australia and New Zealand

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.
  • Maas, A. I., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., ... Chesnut, R. M. (2017). Traumatic brain injury: Integrated approaches to improve prevention, clinical care, and research. The Lancet Neurology, 16 (12), 987-1048. 10.1016/S1474-4422(17)30371-X
  • Bell, R., Te Ao, B., Ironside, N., Bartlett, A., Windsor, J. A., & Pandanaboyana, S. (2017). Meta-analysis and cost effective analysis of portal-superior mesenteric vein resection during pancreatoduodenectomy: Impact on margin status and survival. Surgical Oncology, 26 (1), 53-62. 10.1016/j.suronc.2016.12.007
    Other University of Auckland co-authors: John Windsor, Adam Bartlett
  • Te Ao, B., Brown, P., Fink, J., Vivian, M., & Feigin, V. (2015). Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals. International Journal of Stroke, 10 (6), 903-910. 10.1111/ijs.12152
  • Te Ao, B., Tobias, M., Ameratunga, S., McPherson, K., Theadom, A., Dowell, A., ... Brown, P. (2015). Burden of traumatic brain injury in New Zealand: Incidence, prevalence and disability-adjusted life years. Neuroepidemiology, 44 (4), 255-261. 10.1159/000431043
    Other University of Auckland co-authors: Shanthi Ameratunga, Suzanne Barker-Collo
  • Te Ao, B., Brown, P., Tobias, M., Ameratunga, S., Barker-Collo, S., Theadom, A., ... Jones, K. (2014). Cost of traumatic brain injury in New Zealand: evidence from a population-based study. Neurology, 83 (18), 1645-1652. 10.1212/WNL.0000000000000933
    Other University of Auckland co-authors: Shanthi Ameratunga, Suzanne Barker-Collo
  • Te Ao, B. J., Brown, P. M., Feigin, V. L., & Anderson, C. S. (2012). Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study. International journal of stroke : official journal of the International Stroke Society, 7 (8), 623-630. 10.1111/j.1747-4949.2011.00632.x
  • Panattoni, L., Brown, P. M., Te Ao, B., Webster, M., & Gladding, P. (2012). The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: A New Zealand evaluation. Pharmacoeconomics, 30 (11), 1067-1084. 10.2165/11595080-000000000-00000


Contact details

Primary office location

M&HS BUILDING 507 - Bldg 507
Level 3, Room 3066
New Zealand

Web links